Rx-360 Launches The Traceability Data Exchange Architecture Work Group
Rx-360 is pleased to announce the establishment of a new collaborative work group being set up to support serialisation and track and trace legislation that is evolving globally.
This work group will focus on developing conceptual models for the interoperable exchange of information needed to comply with global regulations. The work group will develop several models that will be discussed at a high level and measured for its merits and impact on the supply chain. The effort will be fast paced and result in a whitepaper for discussion at industry forums by year end and the options could be considered for global pilots.
“This workgroup is a good example of how Rx-360 operates. We are gathering the best minds in the industry to tackle a complex unmet need in the interest of enhancing patient safety. We don’t achieve interoperable systems without addressing the complexities of data exchange” said Rx-360 Chairman Brian Johnson. This workgroup will be tri-chaired by Lloyd Mager (Abbvie), Peggy Staver (Pfizer), and Brian Rezach (Actavis). A call for participation from all industry segments will be issued shortly.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance